Visualitzant tema Sanitari Integral d'Utilització Pública de Catalunya

T1/T2-weighted ratio in multiple sclerosis: A longitudinal study with clinical associations

Boaventura de Oliveira, Mateus; Garcia Vidal, Aran; Vidal Jordana, Angela; Quartana, Davide; Carvajal Junco, René Yeltsin; Auger Acosta, Cristina; Alberich Jordà, Manel; Tintore Subirana, Mar; Rovira Cañellas, Alex; Montalban Gairín, Xavier; Pareto Onghena, Deborah; Sastre Garriga, Jaume (Elsevier, 2022)

T1w/FLAIR ratio standardization as a myelin marker in MS patients

Cappelle, Sarah; Pareto Onghena, Deborah; Sunaert, Stefan; Smets, Ide; Laenen, Annouschka; Dubois, Benedicte; Demaerel, Philippe (Elsevier, 2022)

Tacrolimus CYP3A Single-Nucleotide Polymorphisms and Preformed T- and B-Cell Alloimmune Memory Improve Current Pretransplant Rejection-Risk Stratification in Kidney Transplantation

Crespo Gimeno, Elena Isabel; Vidal-Alabró, Anna; Jouve, Thomas; Fontova, Pere; Stein, Maik; Mocka, Sonila; Meneghini. Maria Antonia Emilia; Torija Recasens, Alba; Donadeu Casassas, Laura; Moreso Mateos, Francesc; Bestard Matamoros, Oriol (Frontiers Media, 2022-06)

Tafasitamab for patients with relapsed or refractory diffuse large B-cell lymphoma: final 5-year efficacy and safety findings in the phase II L-MIND study

Duell, Johannes; André, Marc; GAIDANO, Gianluca; GONZALEZ BARCA, EVA; Jurczak, Wojciech; Abrisqueta, Pau (Ferrata Storti Foundation, 2024-02)

Tailoring of the photocatalytic activity of CeO2 nanoparticles by the presence of plasmonic Ag nanoparticles

Zhao, Shuang; Riedel, Marc; Bastús, Neus G; Franco Puntes, Victor; Yue, Zhao; Lisdat, Fred; Parak, Wolfgang J.; Patarroyo, Javier (Royal Society of Chemistry, 2022-07-27)

Takotsubo syndrome outcomes predicted by thyroid hormone signature: insights from cluster analysis of a multicentre registry

Aweimer, Assem; Dietrich, Johannes W.; Santoro, Francesco; Camins Fàbregas, Mireia; Mügge, Andreas; Nuñez Gil, Ivan Javier; Uribarri, Aitor (Elsevier, 2024-03-18)

TALAPRO-3 clinical trial protocol: phase III study of talazoparib plus enzalutamide in metastatic castration-sensitive prostate cancer

Matsubara, Nobuaki; Agarwal, Neeraj; Saad, Fred; Azad, Arun; Mateo, Joaquin; Shore, Neal (Future Medicine, 2023-10-26)

Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: TALAPRO-2 phase III study design

Agarwal, Neeraj; Azad, Arun; Shore, Neal; Fay, Andre P; Dunshee, Curtis; Carles, Joan (Future Medicine, 2022-02)

Tallers d’educació afectiva i sexual a l’ESO

Adarve-Hidalgo, Eva; Aguilera Gironès, Deborah; Garcia Cuscó, Anna; Jounou Llobera, Maria; Llobera Sanz, Alba; Moreno Buendía, Laura; Olivera Lindez, Sandra; Pallisé Cardellach, Alba; Pérez Martínez, Elena; Polo Zamorano, Ariadna; Rebollo, María Cristina; Salas Martín, Melania; Pilar, Sancho; Scalone, Jessica A. (Institut Català de la Salut, 2021-05)

Targeted long-read sequencing reveals clonally expanded HBV-associated chromosomal translocations in patients with chronic hepatitis B

van Buuren, Nicholas; Ramirez, Ricardo; Soulette, Cameron; Suri, Vithika; Han, Dong; May, Lindsey; Buti Ferret, Maria (Elsevier, 2022-04-01)

Targeted multiplex proteomics for molecular prescreening and biomarker discovery in metastatic colorectal cancer

Garazi, Serna; Cecchi, Fabiola; Fasani, Roberta; Thyparambil, Sheeno; Elez Fernandez, Mª Elena; Vivancos Prellezo, Ana; Tabernero Caturla, Josep; Nuciforo, Paolo Giovanni; Landolfi, Stefania; Ruiz Pace, Fiorella; Jimenez, Jose; Dienstmann, Rodrigo (Nature Publishing Group, 2019-09-19)

Targeting antitumoral proteins to breast cancer by local administration of functional inclusion bodies

Pesarrodona, Mireia; Jauset González, Antoni; Sánchez-Chardi, Alejandro; Seras Franzoso, Joaquin; Baltà Foix, Ricardo; Mancilla Zamora, Sandra; Fernández Amurgo, Yolanda; Schwartz Navarro, Simon; Abasolo Olaortua, Ibane; Diaz Riascos, Zamira Vanessa; Beaulieu, Marie-Eve; Soucek, Laura (Wiley Online Library, 2019-07-24)

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Visualitzant Sistema Sanitari Integral d'Utilització Pública de Catalunya - SISCAT per títol

T1/T2-weighted ratio in multiple sclerosis: A longitudinal study with clinical associations

T1w/FLAIR ratio standardization as a myelin marker in MS patients

Tacrolimus CYP3A Single-Nucleotide Polymorphisms and Preformed T- and B-Cell Alloimmune Memory Improve Current Pretransplant Rejection-Risk Stratification in Kidney Transplantation

Tafasitamab for patients with relapsed or refractory diffuse large B-cell lymphoma: final 5-year efficacy and safety findings in the phase II L-MIND study

Tailoring of the photocatalytic activity of CeO2 nanoparticles by the presence of plasmonic Ag nanoparticles

Takotsubo syndrome outcomes predicted by thyroid hormone signature: insights from cluster analysis of a multicentre registry

TALAPRO-3 clinical trial protocol: phase III study of talazoparib plus enzalutamide in metastatic castration-sensitive prostate cancer

Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: TALAPRO-2 phase III study design

Tallers d’educació afectiva i sexual a l’ESO

Targeted long-read sequencing reveals clonally expanded HBV-associated chromosomal translocations in patients with chronic hepatitis B

Targeted multiplex proteomics for molecular prescreening and biomarker discovery in metastatic colorectal cancer

Targeting antitumoral proteins to breast cancer by local administration of functional inclusion bodies

Targeting DNA Damage Repair Mechanisms in Pancreas Cancer

Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancer

Targeting HIV persistence in the tissue

Targeting KRAS G12C Mutation in Colorectal Cancer, A Review: New Arrows in the Quiver

Targeting mTOR to overcome resistance to hormone and CDK4/6 inhibitors in ER-positive breast cancer models

Targeting MYC-driven lymphoma: lessons learned and future directions

Targeting of the CD80/86 proinflammatory axis as a therapeutic strategy to prevent severe COVID-19

Targeting Sphingolipids for Cancer Therapy

Coneix Scientia

Guies i ajudes

Directe a...

Coneix Scientia

Guies i ajudes

Directe a...

Visualitzant Sistema Sanitari Integral d'Utilització Pública de Catalunya - SISCAT per títol

T1/T2-weighted ratio in multiple sclerosis: A longitudinal study with clinical associations ﻿

T1w/FLAIR ratio standardization as a myelin marker in MS patients ﻿

Tacrolimus CYP3A Single-Nucleotide Polymorphisms and Preformed T- and B-Cell Alloimmune Memory Improve Current Pretransplant Rejection-Risk Stratification in Kidney Transplantation ﻿

Tafasitamab for patients with relapsed or refractory diffuse large B-cell lymphoma: final 5-year efficacy and safety findings in the phase II L-MIND study ﻿

Tailoring of the photocatalytic activity of CeO2 nanoparticles by the presence of plasmonic Ag nanoparticles ﻿

Takotsubo syndrome outcomes predicted by thyroid hormone signature: insights from cluster analysis of a multicentre registry ﻿

TALAPRO-3 clinical trial protocol: phase III study of talazoparib plus enzalutamide in metastatic castration-sensitive prostate cancer ﻿

Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: TALAPRO-2 phase III study design ﻿

Tallers d’educació afectiva i sexual a l’ESO ﻿

Targeted long-read sequencing reveals clonally expanded HBV-associated chromosomal translocations in patients with chronic hepatitis B ﻿

Targeted multiplex proteomics for molecular prescreening and biomarker discovery in metastatic colorectal cancer ﻿

Targeting antitumoral proteins to breast cancer by local administration of functional inclusion bodies ﻿

Targeting DNA Damage Repair Mechanisms in Pancreas Cancer ﻿

Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancer ﻿

Targeting HIV persistence in the tissue ﻿

Targeting KRAS G12C Mutation in Colorectal Cancer, A Review: New Arrows in the Quiver ﻿

Targeting mTOR to overcome resistance to hormone and CDK4/6 inhibitors in ER-positive breast cancer models ﻿

Targeting MYC-driven lymphoma: lessons learned and future directions ﻿

Targeting of the CD80/86 proinflammatory axis as a therapeutic strategy to prevent severe COVID-19 ﻿

Targeting Sphingolipids for Cancer Therapy ﻿

Coneix Scientia

Guies i ajudes

Directe a...

Coneix Scientia

Guies i ajudes

Directe a...

T1/T2-weighted ratio in multiple sclerosis: A longitudinal study with clinical associations

T1w/FLAIR ratio standardization as a myelin marker in MS patients

Tacrolimus CYP3A Single-Nucleotide Polymorphisms and Preformed T- and B-Cell Alloimmune Memory Improve Current Pretransplant Rejection-Risk Stratification in Kidney Transplantation

Tafasitamab for patients with relapsed or refractory diffuse large B-cell lymphoma: final 5-year efficacy and safety findings in the phase II L-MIND study

Tailoring of the photocatalytic activity of CeO2 nanoparticles by the presence of plasmonic Ag nanoparticles

Takotsubo syndrome outcomes predicted by thyroid hormone signature: insights from cluster analysis of a multicentre registry

TALAPRO-3 clinical trial protocol: phase III study of talazoparib plus enzalutamide in metastatic castration-sensitive prostate cancer

Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: TALAPRO-2 phase III study design

Tallers d’educació afectiva i sexual a l’ESO

Targeted long-read sequencing reveals clonally expanded HBV-associated chromosomal translocations in patients with chronic hepatitis B

Targeted multiplex proteomics for molecular prescreening and biomarker discovery in metastatic colorectal cancer

Targeting antitumoral proteins to breast cancer by local administration of functional inclusion bodies

Targeting DNA Damage Repair Mechanisms in Pancreas Cancer

Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancer

Targeting HIV persistence in the tissue

Targeting KRAS G12C Mutation in Colorectal Cancer, A Review: New Arrows in the Quiver

Targeting mTOR to overcome resistance to hormone and CDK4/6 inhibitors in ER-positive breast cancer models

Targeting MYC-driven lymphoma: lessons learned and future directions

Targeting of the CD80/86 proinflammatory axis as a therapeutic strategy to prevent severe COVID-19

Targeting Sphingolipids for Cancer Therapy